High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
In thalassemia, deficient globin-chain production during erythropoiesis results in anemia. Thalassemia may be further complicated by iron overload (frequently exacerbated by blood transfusion), which induces numerous endocrine diseases, hepatic cirrhosis, cardiac failure and even death. Accumulation of iron in the absence of blood transfusions may result from inappropriate suppression of the iron-regulating peptide hepcidin by an erythropoietic mechanism. To test this hypothesis, we examined erythroblast transcriptome profiles from 15 healthy, nonthalassemic donors. Growth differentiation factor 15 (GDF15), a member of the transforming growth factor-beta superfamily, showed increased expression and secretion during erythroblast maturation. Healthy volunteers had mean GDF15 serum concentrations of 450 +/- 50 pg/ml. In comparison, individuals with beta-thalassemia syndromes had elevated GDF15 serum levels (mean 66,000 +/- 9,600 pg/ml; range 4,800-248,000 pg/ml; P < 0.05) that were positively correlated with the levels of soluble transferrin receptor, erythropoietin and ferritin. Serum from thalassemia patients suppressed hepcidin mRNA expression in primary human hepatocytes, and depletion of GDF15 reversed hepcidin suppression. These results suggest that GDF15 overexpression arising from an expanded erythroid compartment contributes to iron overload in thalassemia syndromes by inhibiting hepcidin expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Growth-differentiation factor (GDF)-15, whose levels are increased in thalassemia and AI with or without ID, also inhibits HAMP expression [60, 64].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [60]
In the citing paper
“However, in being the primary iron source for erythropoiesis, TF also indirectly regulates HAMP expression via erythroid progenitor-derived mediators, suggesting that the pathways of HAMP regulation are interconnected [59–61].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [60]
In the citing paper
“Growth differentiation factor 15 (GDF-15) and twisted gastrulation homolog 1 (TWSG1) have been identified as candidate erythrokines, although not erythroblast-specific, that have the potential to suppress hepcidin under conditions of increased erythropoietic activity.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
In the citing paper
“GDF15 is an iron- and O2-regulated (HIF-independent) member of the TGF-β superfamily, which is secreted from maturing erythroblasts and has been shown to suppress hepcidin transcription in primary human hepatocytes and hepatoma cells”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
In the citing paper
“This is in contrast to previous reports where higher doses of GDF15 were needed to achieve hepcidin suppression in human HuH-7 hepatoma cells and in primary hepatocytes, while low dose GDF15 treatment increased hepcidin.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Weatherall, D. J., & Clegg, J. B. (2001) · Wiley eBooks · doi:10.1002/9780470696705 · Cited by 1,069
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026 · cited 1×
“Recently, transforming growth factor-β (TGFB) superfamily members have been identified as regulators of hepcidin expressio”
BackgroundRund, D., & Rachmilewitz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 939
(1973) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb111034.x · Cited by 811
Regulation of Iron Metabolism by Hepcidin
Nemeth, E., & Ganz, T. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111303 · Cited by 756
Self-citationA role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
Wang, R.-H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.010 · Cited by 614 · cited 1×
“Recently, transforming growth factor-β (TGFB) superfamily members have been identified as regulators of hepcidin expressio”
BackgroundSelf-citationXu, J., Kimball, T. R., Lorenz, J. N., Brown, D. A., Bauskin, A. R., Klevitsky, R., Hewett, T. E., Breit, S. N., & Molkentin, J. D. (2006) · Circulation Research · doi:10.1161/01.res.0000202804.84885.d0 · Cited by 506 · cited 1×
“Studies in cardiomyocytes suggest that GDF15 activates Smad2/3 signalin”
BackgroundLarge-Scale Delineation of Secreted Protein Biomarkers Overexpressed in Cancer Tissue and Serum
Welsh, J. B., Sapinoso, L. M., Kern, S. G., Brown, D. A., Liu, T., Bauskin, A. R., Ward, R. L., Hawkins, N. J., Quinn, D. I., Russell, P. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530278100 · Cited by 503 · cited 1×
“Elevated serum GDF15 concentrations have been reported in a variety of cancer”
BackgroundThe transforming growth factor-β superfamily of receptors
de Caestecker, M. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.004 · Cited by 464
Cited by
Items 301–400 of 865
Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II
Casanovas, G., Swinkels, D. W., Altamura, S., Schwarz, K., Laarakkers, C. M., Gross, H.-J., Wiesneth, M., Heimpel, H., & Muckenthaler, M. U. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0751-5 · Cited by 53
“GDF15 concentrations in CDA patients are also lower than those observed in thalassemia patients and lower than those reported to suppress hepcidin synthesis in cultured cells [8].”
Non-HFE hemochromatosis: Pathophysiological and diagnostic aspects
Bardou‐Jacquet, E., Ali, Z. B., Beaumont-Epinette, M.-P., Loréal, O., Jouanolle, A., & Brissot, P. (2013) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2013.11.003 · Cited by 51
The Case for an Estrogen-iron Axis in Health and Disease
Hamad, M. A., Bajbouj, K., & Taneera, J. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0885-1677 · Cited by 50
Kwiatkowski, J. (2011) · Journal of Blood Medicine · doi:10.2147/jbm.s13065 · Cited by 53
“The pathophysiology may be related to elevated levels of GDF15, a bone marrow– derived factor that suppresses hepcidin expression.(6,7) The resulting increased absorption of dietary iron can cause iron overload, which may be further exacerbated by periodic transfusions.”
Koreth, J., & Antin, J. H. (2010) · Haematologica · doi:10.3324/haematol.2009.017244 · Cited by 48
Macrophages as a Source and Target of GDF-15
Silva-Bermúdez, L. S., Klüter, H., & Kzhyshkowska, J. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137313 · Cited by 48
Potential Roles of BMP9 in Liver Fibrosis
Bi, J., & Ge, S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151120656 · Cited by 51
“These phenomena are more significant in patients with cirrhosis and are negatively correlated with serum ferritin levels and liver iron content [67–69].”
BackgroundJiang, X., Gao, M., Chen, Y., Liu, J. L., Qi, S., Ma, J., Zhang, Z., & Xu, Y. H. (2016) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2016.02.005 · Cited by 49
The global burden of iron overload
Wood, M. J., Skoien, R., & Powell, L. W. (2009) · Hepatology International · doi:10.1007/s12072-009-9144-z · Cited by 48
“In these disorders, iron absorption is increased via downregulation of hepcidin [32].”
BackgroundNormal and dysregulated crosstalk between iron metabolism and erythropoiesis
Ginzburg, Y. Z., An, X., Rivella, S., & Goldfarb, A. N. (2023) · eLife · doi:10.7554/elife.90189 · Cited by 51
“For example, although circulating growth differentiation factor 15 (GDF15) increases in patients with some congenital and acquired anemias and inversely correlates with hepcidin (Tanno et al., 2007), levels of GDF15 and hepcidin correlate poorly in phlebotomized mice (Casanovas et al.”
BackgroundGDF15: from biomarker to target in cancer cachexia
Hüllwegen, M., Kleinert, M., von Haehling, S., & Fischer, A. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.06.007 · Cited by 48
Iron Metabolism and Iron Chelation in Sickle Cell Disease
Walter, P. B., Harmatz, P., & Vichinsky, E. P. (2009) · Acta Haematologica · doi:10.1159/000243802 · Cited by 46
“However, the expanded erythroid compartment in hemoglobinopathies such as thalassemia secretes high levels of GDF15, which most likely leads to iron overload by its ability to inhibit hepcidin expression [”
BackgroundErythropoiesis and Iron Sulfur Cluster Biogenesis
Ye, H., & Rouault, T. A. (2010) · Advances in Hematology · doi:10.1155/2010/329394 · Cited by 50
“To coordinate iron metabolism to meet the demands of erythropoiesis, hepcidin expression is regulated by EPO, the erythropoiesis stimulator, and also possibly by growth differentiation factor 15 (GDF15) and twisted gastrulation (TWSG1), soluble peptides which are directly produced by erythroblasts [20, 21].”
BackgroundCystathionine β‐synthase is required for body iron homeostasis
Zhou, Y., Wu, X., Zhou, G., Mu, M., Zhang, F., Li, F., Qian, C., Du, F., Yung, W., Qian, Z., et al. (2017) · Hepatology · doi:10.1002/hep.29499 · Cited by 45
“It has been well demonstrated that the expression of TfR1, DMT1, and Fpn1 is coordinately regulated by the IRP/iron-responsive element (IRE) system,((43,44,46,47)) positively for the 30 untranslated region IRE motif in TfR1 and the 30 untranslated region IRE motif in DMT1 and negatively for the 50 untranslated region…”
BackgroundThe role of iron in patients after bone marrow transplantation
de Witte, T. (2008) · Blood Reviews · doi:10.1016/s0268-960x(08)70005-5 · Cited by 45
Zakharova, E. T., Kostevich, V. A., Av, S., & Vasilyev, V. B. (2012) · BioMetals · doi:10.1007/s10534-012-9586-y · Cited by 45
“The latter suppresses the synthesis of hepcidin, the factor favoring iron deficiency (Tanno et al. 2007).”
BackgroundMethodological considerations for measuring biofluid-based microRNA biomarkers
Chorley, B. N., Atabakhsh, E., Doran, G., Gautier, J., Ellinger-Ziegelbauer, H. C., Jackson, D. A., Sharapova, T., Yuen, P. S. T., Church, R. J., Couttet, P., et al. (2021) · Critical Reviews in Toxicology · doi:10.1080/10408444.2021.1907530 · Cited by 47
“2005); however, higher baseline or signal variability can generally only be overcome by a robust responsive signal (Tanno et al. 2007).”
BackgroundTang, Y., Li, Y., Yu, H., Gao, C., Liu, L., Chen, S., Xing, M., Liu, L., & Yao, P. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.02.009 · Cited by 45
“transferrin receptor complex (HFE/TfR) [10], extracellular signalregulated kinase/mitogen-activated protein kinase (ERK/MAPK) [11], interleukin 6 (IL6)/signal transducer and activator of transcription (STAT) [12], growth differentiation factor 15 (GDF15), and twisted gastrulation 1 (TWSG1) [13,14].”
BackgroundRishi, G., Secondes, E. S., Wallace, D. F., & Subramaniam, V. N. (2016) · American Journal of Hematology · doi:10.1002/ajh.24417 · Cited by 45
“Although the exact molecular details of this regulation are not well understood, it is believed that the erythroid compartment releases a soluble factor which limits the production of Hamp in the liver [4].”
BackgroundIron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
Bou‐Fakhredin, R., Bazarbachi, A. H., Chaya, B. F., Sleiman, J., Cappellini, M. D., & Taher, A. T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122778 · Cited by 44
“The downregulation of hepcidin in NTDT can also be mediated by growth differentiation factor-15 (GDF-15) [11,13,14] and twisted gastrulation factor [15].”
BackgroundFunctional roles of GDF15 in modulating microenvironment to promote carcinogenesis
Rochette, L., Méloux, A., Zeller, M., Cottin, Y., & Vergely, C. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165798 · Cited by 44
Coping With Stress: The Mitokine GDF-15 as a Biomarker of COVID-19 Severity
Ahmed, D. S., Isnard, S., Berini, C. A., Lin, J. C.-Y., Routy, J., & Royston, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.820350 · Cited by 47
“GDF-15 is inversely associated with hepcidin, a key regulator in systemic iron homeostasis in mammals (74, 90, 92), expediting intestinal iron absorption leading to iron overload (93, 94).”
BackgroundFrazer, D. M., Wilkins, S. J., Darshan, D., Badrick, A. C., McLaren, G. D., & Anderson, G. J. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09104.x · Cited by 43
Genetic similarity between cancers and comorbid Mendelian diseases identifies candidate driver genes
Melamed, R., Emmett, K., Madubata, C. J., Rzhetsky, A., & Rabadán, R. (2015) · Nature Communications · doi:10.1038/ncomms8033 · Cited by 44
Erythroferrone contributes to hepcidin repression in a mouse model of malarial anemia
Latour, C., Wlodarczyk, M. F., Jung, G., Gineste, A., Blanchard, N., Ganz, T., Roth, M.-P., Coppin, H., & Kautz, L. (2017) · Haematologica · doi:10.3324/haematol.2016.150227 · Cited by 43
Self-citationUnexplained Aspects of Anemia of Inflammation
Price, E. A., & Schrier, S. L. (2010) · Advances in Hematology · doi:10.1155/2010/508739 · Cited by 51
“Plasma growth differentiation factor-15 (GDF15) levels, which are elevated in thalassemia major and inhibit hepdcidin synthesis [34], did not appear to negatively regulate hepcidin in this setting, consistent with results in normal volunteers treated with low-dose recombinant human erythropoietin [35].”
ResultHemoglobin, Iron, and Bilirubin
Higgins, T., Eckfeldt, J. H., Barton, J. C., & Doumas, B. T. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6164-9.00032-9 · Cited by 53
Theurl, M., Nairz, M., Schroll, A., Sonnweber, T., Asshoff, M., Haschka, D., Seifert, M., Willenbacher, W., Wilflingseder, D., Posch, W., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.099481 · Cited by 42
Unraveling Mechanisms Regulating Systemic Iron Homeostasis
Finberg, K. E. (2011) · Hematology · doi:10.1182/asheducation-2011.1.532 · Cited by 39
Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis
Sikorska, K., Bernat, A., & Wróblewska, A. (2016) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(16)60135-2 · Cited by 46
de Haan, J. J., Haitjema, S., den Ruijter, H. M., Pasterkamp, G., de Borst, G. J., Teraa, M., Verhaar, M. C., Gremmels, H., & de Jager, S. C. A. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006225 · Cited by 43
“GDF15 has been linked to anemia in various pathogenic conditions, such as chronic heart failure, 13,41 thalassemia, 42 and pyruvate kinase de fi ciency, 43 and in kidney 44 or heart 41 allograft recipients.”
Controversies on the Consequences of Iron Overload and Chelation in MDS
Vinchi, F., Hell, S., & Platzbecker, U. (2020) · HemaSphere · doi:10.1097/hs9.0000000000000357 · Cited by 42
“Whether it is the only factor controlling hepcidin suppression during enhanced erythropoiesis is unclear and other molecules, including GDF15 (Growth Differentiation Factor 15), TWSG1 (Twisted gastrulation homolog protein 1) and PDGF-BB (Platelet-derived growth factor-BB), have been implicated, though not so definitel…”
BackgroundTumor Immune Evasion Induced by Dysregulation of Erythroid Progenitor Cells Development
Grzywa, T. M., Justyniarska, M., Nowis, D., & Gołąb, J. (2021) · Cancers · doi:10.3390/cancers13040870 · Cited by 43
“Erythropoiesis is also suppressed by GDF15, which modulates iron metabolism [186].”
BackgroundKartikasari, A. E. R., Wagener, F. A. D. T. G., Yachie, A., Wiegerinck, E. T. G., Kemna, E., & Winkels, D. W. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00494.x · Cited by 45
“The patient’s decreased serum hepcidin levels are thus likely to be the result of increased erythroid expansion that, by analogy with growth differentation factor-15 exclusively present in -thalassaemia [35] through the systemic release of a thus far unknown factor, down-regulates hepatocyte hepcidin production.”
COX inhibitors directly alter gene expression: role in cancer prevention?
Wang, X., Baek, S. J., & Eling, T. E. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9301-4 · Cited by 41
“In beta thalassemia, a mean concentration of NAG-1 in the blood as high as 66±10 ng/ml has been reported [99].”
InfluentialSelf-citationImbalance of erythropoiesis and iron metabolism in patients with thalassemia
Huang, Y., Yu, L., Liu, R., Liu, J., Yang, G., Xiang, Z., Liang, Y., & Lai, Y. (2019) · International Journal of Medical Sciences · doi:10.7150/ijms.27829 · Cited by 42
“The expansion of the erythroid compartment leads to the overexpression of GDF15, which inhibits the expression of hepcidin, ultimately leading to iron overload [7].”
BackgroundAltered erythropoiesis and iron metabolism in carriers of thalassemia
Guimarães, J. D. S., Cominal, J. G., Silva‐Pinto, A. C., Olbina, G., Ginzburg, Y. Z., Nandi, V., Westerman, M. E., Rivella, S., & de Souza, A. M. (2014) · European Journal Of Haematology · doi:10.1111/ejh.12464 · Cited by 42
“(22) suggested that GDF15 levels in normal individuals were between 200 and 1150 pg/mL.”
BackgroundIron Deficiency Anaemia and Iron Overload
Worwood, M., May, A. M., & Bain, B. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6696-2.00009-6 · Cited by 43
Patel, N., Varghese, J., Masaratana, P., Latunde‐Dada, G. O., Jacob, M., Simpson, R. J., & McKie, A. T. (2014) · British Journal of Haematology · doi:10.1111/bjh.12649 · Cited by 36
“…precursors, and bone morphogenic protein binding endothelial cell precursor-derived regulator (BMPER), produced by endothelial cells, have all been postulated to play a role in the suppression of HAMP (Tanno et al, 2007, 2009; Patel et al, 2012) by, in most cases, inhibiting BMP signalling.”
BackgroundDEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
Taher, A. (2018) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2018.066 · Cited by 41
Novel Therapeutic Advances in β-Thalassemia
Makis, A. C., Voskaridou, E., Papassotiriou, I., & Hatzimichael, E. C. (2021) · Biology · doi:10.3390/biology10060546 · Cited by 43
Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancy
Finkenstedt, A., Widschwendter, A., Brasse‐Lagnel, C., Theurl, I., Hubalek, M., Dieplinger, H., Tselepis, C., Ward, D. G., Vogel, W., & Zoller, H. (2012) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2012.02.001 · Cited by 42
HEPCIDIN, ANAEMIA, AND PROSTATE CANCER
Tanno, T., Rabel, A., Alleyne, M., Lee, Y. T., Dahut, W. L., Gulley, J. L., & Miller, J. L. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10108.x · Cited by 41
“ELISA-based assay systems were used to examine the serum levels of hepcidin, GDF15 and IL-6 [6, 7].”
BackgroundMethodSelf-citationHereditary hemochromatosis and transferrin receptor 2
Chen, J., & Enns, C. A. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.07.015 · Cited by 47
“Tanno and colleagues identified two genes with elevated mRNAs in murine models of thalassemias [67].”
BackgroundHepcidin and β-thalassemia major
Nemeth, E. (2013) · Blood · doi:10.1182/blood-2013-05-502617 · Cited by 35
“GDF-15 has been proposed as a hepcidin suppressor in b-thalassemia.(7) GDF-15 is secreted by late and apoptotic erythroblasts, and its levels are greatly elevated in human b-thalassemia patients, although not in a thalassemia mouse model.”
BackgroundSteensma, D. P., & Gattermann, N. (2013) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2013.09.009 · Cited by 43
“In thalassaemia major, hepcidin is suppressed by dramatically elevated expression of Growth Differentiation Factor 15 (GDF15), a transforming growth factor-b superfamily member that is secreted by maturing erythroblasts is the bone marrow [9].”
BackgroundSoni, S. (2020) · American Journal of Hematology · doi:10.1002/ajh.25909 · Cited by 41
“hepcidin:ferritin ratio, GDF15, soluble transferrin receptor levels) is important to study in early clinical trials, to establish proof of efficacy.(74,75)”
BackgroundRider, N. L., Strauss, K. A., Brown, K., Finkenstedt, A., Puffenberger, E. G., Hendrickson, C. L., Robinson, D. L., Muenke, N., Tselepis, C., Saunders, L., et al. (2011) · American Journal of Hematology · doi:10.1002/ajh.22118 · Cited by 38
“GDF-15, produced by erythrocyte precursors, antagonizes hepcidin function [22,23].”
BackgroundInsight onto the Pathophysiology and Clinical Complications of Thalassemia Intermedia
Cappellini, M. D., Musallam, K. M., & Taher, A. T. (2009) · Hemoglobin · doi:10.3109/03630260903351528 · Cited by 38
“Recent studies indicate that growth and differentiation factor 15 (GDF15), secreted by erythroid precursors, are significantly increased in patients with TM, inhibiting hepcidin production (24).”
BackgroundModifier genes in Mendelian disorders: the example of hemoglobin disorders
Sankaran, V. G., Lettre, G., Orkin, S. H., & Hirschhorn, J. N. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05821.x · Cited by 40
Sardo, U., Perrier, P., Cormier, K., Sotin, M., Personnaz, J., Medjbeur, T., Desquesnes, A., Cannizzo, L., Ruíz-Martínez, M., Thevenin, J., et al. (2024) · Blood · doi:10.1182/blood.2023022724 · Cited by 41
Self-citationErythropoietic drive is the strongest predictor of hepcidin level in adults with sickle cell disease
Karafin, M. S., Koch, K. L., Rankin, A. B., Nischik, D., Rahhal, G., Simpson, P. M., & Field, J. J. (2015) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2015.07.010 · Cited by 37
“Instead, EPO is thought to stimulate erythroid precursors to produce proteins (growth differentiation factor 15 (GDF15), twisted gastrulation protein (TWSG1), and erythroferrone) which act to suppress hepcidin in the context of ineffective erythropoiesis [24,29,31,32].”
BackgroundLiver iron modulates hepcidin expression during chronically elevated erythropoiesis in mice
Díaz, V., Gammella, E., Recalcati, S., Santambrogio, P., Naldi, A. M., Vogel, J., Gassmann, M., & Cairo, G. (2013) · Hepatology · doi:10.1002/hep.26550 · Cited by 40
Influence of post-exercise hypoxic exposure on hepcidin response in athletes
Badenhorst, C. E., DAWSON, B. T., Goodman, C., Sim, M., Cox, G. R., Gore, C. J., Tjalsma, H., Swinkels, D. W., & Peeling, P. (2014) · European Journal of Applied Physiology · doi:10.1007/s00421-014-2829-6 · Cited by 37
Bajbouj, K., Shafarin, J., Allam, H., Madkour, M. I., Awadallah, S. M., El-Serafi, A. T., Sandeep, D., & Hamad, M. A. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-124077 · Cited by 38
Schaefer, B., Haschka, D., Finkenstedt, A., Petersen, B.-S., Theurl, I., Henninger, B., Janecke, A. R., Wang, C.-Y., Lin, H. Y., Veits, L., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv348 · Cited by 35
Mohanty, J. G., Nagababu, E., Friedman, J. S., & Rifkind, J. M. (2012) · Experimental Hematology · doi:10.1016/j.exphem.2012.10.017 · Cited by 37
“[35], people with thalassemia also suffer from iron overload independent of blood transfusions.”
BackgroundHepcidin Expression in Iron Overload Diseases Is Variably Modulated by Circulating Factors
Ravasi, G., Pelucchi, S., Trombini, P., Mariani, R., Tomosugi, N., Modignani, G. L., Pozzi, M., Nemeth, E., Ganz, T., Hayashi, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036425 · Cited by 37
“sera of patients with THAL down-regulated hepcidin synthesis as previously reported [33]; b.”
ResultSelf-citationIron and colorectal cancer: evidence from in vitro and animal studies
Padmanabhan, H., Brookes, M., & Iqbal, T. H. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuu015 · Cited by 40
The relationship between systemic iron homeostasis and erythropoiesis
Rishi, G., & Subramaniam, V. N. (2017) · Bioscience Reports · doi:10.1042/bsr20170195 · Cited by 39
Tanno, T., Rabel, A., Lee, Y. T., Yau, Y. Y., Leitman, S. F., & Miller, J. L. (2010) · Transfusion · doi:10.1111/j.1537-2995.2010.02601.x · Cited by 34
“It was recently demonstrated that human erythroblasts secrete a cytokine named growth differentiation factor 15 (GDF15) that contributes to the inhibition of hepcidin in pathologic conditions.(7) As a p53 target gene,(8) it was proposed that GDF15 is secreted from apoptotic erythroblasts in clinical settings of ineffe…”
BackgroundSelf-citationUeda, T., Yokota, T., Okuzaki, D., Uno, Y., Mashimo, T., Kubota, Y., Sudo, T., Ishibashi, T., Shingai, Y., Doi, Y., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.11.002 · Cited by 34
“In addition, we observed that Gdf15, which promotes hemoglobin synthesis by suppressing hepcidin secretion (Tanno et al., 2007), was the most strongly induced gene following ESAM crosslinking (Figure S4B).”
BackgroundUrinary hepcidin excretion in patients with myelodysplastic syndrome and myelofibrosis
Winder, A., Lefkowitz, R., Ghoti, H., Leiba, M., Ganz, T., Nemeth, E., & Rachmilewitz, E. A. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07225.x · Cited by 34
“…of an erythroid regulator, GDF15, identified in the sera of patients with thalassaemia, which was present in lower amounts in sera from ª 2008 The Authors 670 Journal Compilation ª 2008 Blackwell Publishing Ltd, British Journal of Haematology, 142, 668–680 patients with MDS (Tanno et al, 2007).”
BackgroundSelf-citationGhoti, H., Fibach, E., Westerman, M. E., Olbina, G., Ganz, T., & Rachmilewitz, E. A. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08587.x · Cited by 34
Self-citationRicchi, P., Ammirabile, M., Costantini, S., Matola, T. D., Verna, R., Diano, A. A., Foglia, M. C., Spasiano, A., Cinque, P., & Prossomariti, L. (2011) · Annals of Hematology · doi:10.1007/s00277-011-1385-y · Cited by 33
“factor 15 (GDF15), and unknown “erythroid regulators” that control both the tendency to develop EMH and iron loading [15, 21].”
BackgroundNew and old players in the hepcidin pathway
Camaschella, C., & Silvestri, L. (2008) · Haematologica · doi:10.3324/haematol.13724 · Cited by 33
“Growth differentiation factor 15 (GDF15), a member of the BMP/TGF-β superfamily is another candidate hepcidin inhibitor, since at a very high concentration it may partially suppress hepcidin transcription in primary hepatocyte cultures and in hepatoma cell lines.(32) GDF15, released in large amounts by the erythroblas…”
BackgroundIron overload in patients with myelodysplastic syndromes: An updated overview
Moukalled, N. M., Rassi, F. A. E., Temraz, S. N., & Taher, A. T. (2018) · Cancer · doi:10.1002/cncr.31550 · Cited by 34
Iron and oxygen sensing: a tale of 2 interacting elements?
Simpson, R. J., & McKie, A. T. (2015) · Metallomics · doi:10.1039/c4mt00225c · Cited by 34
Barman‐Aksözen, J., Girelli, D., Aurizi, C., Schneider‐Yin, X., Campostrini, N., Barbieri, L., Minder, E. I., & Biolcati, G. (2017) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-017-0017-7 · Cited by 33
“GDF15 has been proposed as a molecule that signals the erythropoietic activity in thalassemia, as it increases intestinal iron absorption by way of blocking hepcidin synthesis in the liver (Tanno et al. 2007; Musallam et al. 2011).”
BackgroundVarghese, J., James, J. V., Anand, R., Narayanasamy, M., Rebekah, G. J., Ramakrishna, B., Nellickal, A. J., & Jacob, M. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108441 · Cited by 32
“GDF-15 is one of the putative erythroid regulators of hepcidin [52].”
BackgroundFertrin, K. Y., Lanaro, C., Franco‐Penteado, C. F., de Albuquerque, D. M., de Mello, M. R. B., Pallis, F. R., Bezerra, M. A. C., Hatzlhofer, B. L. D., Olbina, G., Saad, S. T. O., et al. (2014) · American Journal of Hematology · doi:10.1002/ajh.23649 · Cited by 32
“such as thalassemias [3,5] and congenital dyserythropoietic anemias [2,4], to increasingly more prevalent acquired conditions, such as myelodys-”
BackgroundA critical role for murine transferrin receptor 2 in erythropoiesis during iron restriction
Wallace, D. F., Secondes, E. S., Rishi, G., Ostini, L., McDonald, C. J., Lane, S. W., Vu, T., Hooper, J. D., Velasco, G., Ramsay, A. J., et al. (2015) · British Journal of Haematology · doi:10.1111/bjh.13225 · Cited by 31
Regulation of Iron Absorption in Hemoglobinopathies
Rechavi, G., & Rivella, S. (2008) · Current Molecular Medicine · doi:10.2174/156652408786241401 · Cited by 35
Recent advances in the understanding of iron overload in sideroblastic myelodysplastic syndrome
Cuijpers, M. L. H., Raymakers, R. A. P., MacKenzie, M. A., De Witte, T. J. M., & Swinkels, D. W. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08051.x · Cited by 32
“Serum GDF15 levels were found to be substantially increased in patients with RARS compared with normal individuals (Ramirez et al, 2009).”
BackgroundInfluentialPerez, E., Baker, J. R., Giandomenico, S. D., Kermani, P., Parker, J., Kim, K., Yang, J., Barnes, P. J., Vaulont, S., Scandura, J. M., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901284 · Cited by 32
“Abbreviations used in this article: AM, alveolar macrophage; BAL, bronchoalveolar lavage; BALF, BAL fluid; COPD, chronic obstructive pulmonary disease; CS, cigarette smoke; CSE, CS extract; DFO, deferoxamine; EFRE, erythroferrone; EPO, erythropoietin; GDF15, growth differentiation factor 15; MDM, monocyte-derived macr…”
BackgroundInfluentialImpact of bacterial infections on erythropoiesis
de Souza, L. V., Hoffmann, A., & Weiß, G. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1841636 · Cited by 32
“platelet derived growth factor-BB [13,14,16,115,116], which ensure a sufficient availability of iron for erythropoiesis.”
BackgroundNovel insights into alcoholic liver disease: Iron overload, iron sensing and hemolysis
Mueller, S., Chen, C., Mueller, J. H., & Wang, S. (2022) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2021-0056 · Cited by 34
Zhang, M., Liu, J., Guo, W., Liu, X., Liu, S., & Yin, H.-J. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2545 · Cited by 33
Hepcidin and GDF15 in anemia of multiple myeloma
Mei, S.-C., Wang, H., Fu, R., Qü, W., Xing, L., Wang, G., Song, J., Liu, H., Li, L., Wang, X., et al. (2014) · International Journal of Hematology · doi:10.1007/s12185-014-1626-7 · Cited by 34
“[7] proved that high GDF15 expression could inhibit the secretion of hepcidin in Mediterranean anemia patients.”
BackgroundOriga, R., Cazzola, M., Mereu, E., Danjou, F., Barella, S., Giagu, N., Galanello, R., & Swinkels, D. W. (2015) · Haematologica · doi:10.3324/haematol.2014.115733 · Cited by 31
“These observations are consistent with GDF15 as the factor contributing most to inhibition of hepcidin levels, in agreement with its previously proposed causal role in the IE- hepcidin-ferritin cascade.(6) In addition, both the hepcidin/ferritin ratio and the hepcidin/ LIC ratio were roughly 10-fold lower for TI than…”
BackgroundResultMorbidities in non‐transfusion‐dependent thalassemia
Saliba, A. N., & Taher, A. T. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13083 · Cited by 35
Russo, R., Andolfo, I., Manna, F., Rosa, G. D., Falco, L. D., Gambale, A., Bruno, M., Mattè, A., Ricchi, P., Girelli, D., et al. (2016) · Blood · doi:10.1182/blood-2016-06-724328 · Cited by 31
Sanctis, V. D. (2018) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2018.064 · Cited by 30
“Increased GI tract iron absorption can result from severe anemia and ineffective erythropoiesis (IE), which downregulate the synthesis of hepcidin, a protein that controls iron absorption from the GI tract and the release of recycled iron from macrophages.(2) Without correction, iron overload can lead to end-”
BackgroundKeel, S., Doty, R. T., Liu, L., Nemeth, E., Cherian, S., Ganz, T., & Abkowitz, J. L. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.03.001 · Cited by 30
“The erythrokine growth differentiation factor 15 (GDF-15), which is markedly elevated in βthalassemic serum, was identified as one possible regulator in pathologic states [12], though some data refute this [13].”
BackgroundResultSelf-citationHepcidin: a real-time biomarker of iron need
Hare, D. J. (2017) · Metallomics · doi:10.1039/c7mt00047b · Cited by 35
Mechanisms and Regulation of Intestinal Iron Transport
Collins, J. F., Flores, S. R., Wang, X., & Anderson, G. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00060-8 · Cited by 34
Fung, E. B., Harmatz, P., Milet, M., Balasa, V., Ballas, S. K., Casella, J. F., Hilliard, L., Kutlar, A., McClain, K. L., Olivieri, N. F., et al. (2008) · Transfusion · doi:10.1111/j.1537-2995.2008.01775.x · Cited by 30
“Increased iron absorption in Thal is most likely due to ineffective erythropoiesis leading to inhibition of hepcidin synthesis in the liver.(30) Given this, even patients with Thal who did not receive transfusions should be monitored on a regular basis and treated when necessary to avoid iron-related organ dysfunction…”
BackgroundGDF-15, iron, and inflammation in early chronic kidney disease among elderly patients
Łukaszyk, E., Łukaszyk, M., Koc‐Żórawska, E., Bodzenta‐Łukaszyk, A., & Małyszko, J. (2016) · International Urology and Nephrology · doi:10.1007/s11255-016-1278-z · Cited by 32
“It has been shown that high concentration of GDF-15 is responsible for the reduced synthesis of hepcidin [5].”
BackgroundToo much iron: A masked foe for leukemias
Brissot, É., Bernard, D. G., Loréal, O., Brissot, P., & Troadec, M. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100617 · Cited by 30
Mojzíková, R., Kořalková, P., Holub, D., Zidova, Z., Pospíšilová, D., Čermák, J., Striezencova, Z. L., Indrák, K., Suková, M., Partschova, M., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.12779 · Cited by 29
“The negative correlation between hepcidin and GDF15 was first reported in patients with b-thalassaemia (Tanno et al, 2007).”
BackgroundRapid and inexpensive blood typing on thermoplastic chips
Chen, J.-Y., Huang, Y.-T., Chou, H.-H., Wang, C.-P., & Chen, C. (2015) · Lab on a Chip · doi:10.1039/c5lc01172h · Cited by 29
Bajbouj, K., Shafarin, J., Abdalla, M. Y., Ahmad, I. M., & Hamad, M. A. (2017) · Tumor Biology · doi:10.1177/1010428317726184 · Cited by 31
AML: high serum ferritin at initial diagnosis has a negative impact on long-term survival
Ihlow, J., Gross, S., Sick, A., Schneider, T., Flörcken, A., Burmeister, T., Türkmen, S., Arnold, R., Dörken, B., & Westermann, J. (2018) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2018.1461860 · Cited by 30
“Considering the iron-storage function of ferritin [9,30], the overall elevated baseline SF level could be explained by either an increased iron uptake from the intestine aiming at a compensation for ineffective hematopoiesis that may be observed in hematologic malignancies [31,32] or by a higher transfusion frequency…”
BackgroundWallace, D. F., & Subramaniam, V. N. (2015) · International Immunology · doi:10.1093/intimm/dxu144 · Cited by 28
20 years of Hepcidin: How far we have come
Colucci, S., Marques, O., & Altamura, S. (2021) · Seminars in Hematology · doi:10.1053/j.seminhematol.2021.05.001 · Cited by 30
Molecular Mechanisms Regulating Hepcidin Revealed by Hepcidin Disorders
Camaschella, C., & Silvestri, L. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.130 · Cited by 35
“The levels of GDF15 that are able to suppress hepcidin transcription in hepatocyte cultures (and less efficiently in hepatoma cell lines)[53] are not observed in other conditions of ineffective erythropoiesis, such as congenital dyserythropoietic anemia type I[55].”
BackgroundFerroportin and Erythroid Cells: An Update
Cianetti, L., Gabbianelli, M., & Sposi, N. M. (2010) · Advances in Hematology · doi:10.1155/2010/404173 · Cited by 31
“Also GDF15 could be another potential therapeutic target for beta-thalassemia syndromes [85].”
BackgroundInfluentialRegulation of hepcidin through GDF-15 in cancer-related anemia
Jiang, F., Yu, W., Wang, X.-H., Tang, Y., Guo, L., & Jiao, X. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.10.015 · Cited by 29
New strategies to target iron metabolism for the treatment of beta thalassemia
Oikonomidou, P. R., Casu, C., & Rivella, S. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13018 · Cited by 28
Characterization of Putative Erythroid Regulators of Hepcidin in Mouse Models of Anemia
Mirciov, C. S. G., Wilkins, S. J., Dunn, L. A., Anderson, G. J., & Frazer, D. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171054 · Cited by 28
Metadata
- Authors
- Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., Eling, T. E., Childs, R., Ganz, T., Leitman, S. F., Fucharoen, S., & Miller, J. L.
- Affiliations
- National Institutes of Health (US)
- Walter Reed National Military Medical Center (US)
- Children's National (US)
- University of California, Los Angeles (US)
- Mahidol University (TH)
- Corresponding author
- Miller, Jeffery L
- Venue
- Nature Medicine
- Published
- 2007-08-26
- Volume
- 13
- Issue
- 9
- Pages
- 1096-1101
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2107423980
- Cited by
- 854
- References
- 32
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 15 · 2023: 26 · 2022: 27 · 2021: 52 · 2020: 40 · 2019: 37 · 2018: 44 · 2017: 45 · 2016: 47 · 2015: 55 · 2014: 55 · 2013: 54 · 2012: 53
- FWCI
- 40.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › GDF15 and Related Biomarkers
- Keywords
- GDF15, growth differentiation factor 15, beta-thalassemia, hepcidin, iron overload, erythropoiesis, erythroblasts, soluble transferrin receptor, ferritin, erythropoietin, hepatocytes, iron regulation
- MeSH terms
- Gene Expression Regulation, Humans, Reference Values, RNA, Messenger, Thalassemia, Transcription, Genetic, Polymerase Chain Reaction, Cytokines, Gene Expression Profiling, Antimicrobial Cationic Peptides, Growth Differentiation Factor 15, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.